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ABSTRACT 
Objective: The aim of this study is to re-evaluate the relationship between smoking and lung cancer. 
Methods: In order to clarify the relationship between cigarette smoking and lung cancer, a review and meta-analysis of appropriate studies with 
a total sample size of n = 48393 was conducted. The p-value was set to p < 0,05.  
Results: It was not possible to reject the null-hypothesis H0: without smoking no lung cancer. Furthermore, the null-hypothesis H0: No causal 
relationship between smoking and lung cancer was rejected. 
Conclusions: Compared to the results from previous studies, the results of this study confirm previously published results. According the results 
of this study, without smoking no lung cancer. Smoking is the cause of lung cancer. 
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INTRODUCTION 
Formerly, lung cancer (LC), was an obscure and uncommon 
disease. Hasse reported in the late 1840s about 22 
ever-published cases of lung cancer1. Meanwhile, lung cancer 
is one of the deadliest and most prevalent human cancers. 
The incidence and mortality rates of lung cancer, the first 
among all cancer types2 , are still high. About 2093876 new 
cases of lung cancer occurred globally in 20183. Furthermore, 
in the year 2018 about 1761007 people died from lung 
cancer. To date, lung cancer is the leading cause of cancer 
related death worldwide. Especially small-cell lung cancer 
(SCLC) is characterized by its rapid growth and high 
response rates to chemotherapy and radiotherapy. The 
prognosis of SCLC depends more or less on the tumor stage. 
By time, the five-year survival rates of lung cancer patients 
remain low at 10% and have only slightly improved during 
the past decade4. A series of investigations and risk analyses 
indicated that factors such as smoking, air pollution, and 
occupational exposure (e.g. asbestos) are somehow related to 
lung cancer but the etiology of lung cancer is not yet clear. 
Especially smoking has been closely linked to lung cancer. 
The tobacco smoke includes about 7000 kinds of chemical 
substance. Carcinogens such as N'-nitrosonornicotine (NNN), 
benzo[a]pyrene, and (methylnitrosamino)-1-(3-pyridyl)- 
1-butanone (NNK) are rich in the stream of tobacco smoke. 
The relationship between the use of tobacco smoke and lung 
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cancer is discussed in literature since more than 80 years 
while the historical origins of the discovery that smoking is 
related to lung cancer are complex5 . The first association was 
documented by a case–control study conducted in Germany 
in the 1930s by Müller6,7. Preliminary evidence has been 
provided that smoking cessation even after diagnosis of early 
stage lung cancer may improve the prognostic outcomes8.  
MATERIAL AND METHODS 
Search strategy 
The articles that met inclusion criteria were identified by 
Google Scholar and by searching in PubMed. The reference 
lists of review-articles were manually scanned to identify 
additional relevant studies. 
Study selection 
To be eligible for inclusion, the papers published have the 
following inclusion criteria: (1) published in English 
language; (2) no data access barriers. The exclusion criteria 
were as follows: (1) sample size less than n=1000. The titles 
and abstracts of all the retrieved articles using the inclusion 
criteria were screened. Data extraction was performed on 
included articles
 
1. Identification of records Size Total 
 Records identified by searching in the databases   
  PubMed 7798  
  Google Scholar  0  
  Web of Science 0  
 Additional records identified from other sources 2 7800 
2. Clean up of search   
 Records removed after verifying duplication 1  
 Records excluded by title 6989  
 Records excluded by the summary 
(Articles outside the inclusion criteria) 
523 287 
3. Eligibility   
 Articles evaluated for eligibility 287  
 Articles excluded for various reasons   
 - Sample size less than 1000 241  
 - Data access barriers 35  
4. Included   
 Articles included in the meta-analysis  11 
Figure 1: Flow Diagram of the article selection process. Adopted from PRISMA9, 10 2009. 
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Data analysis 
The following6, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 data were recorded for analysis. 
Table 1: Without smoking no lung cancer 
Study ID Year N Case_P Case_T Con_P Con_T Odds Ratio OR lower OR upper p(SINE) X2 (SINE) p Value (SINE) k IOU 
Müller 1939 172 83 86 30 86 51,64 15,03 177,45 0,98256 0,1046511628 0,7463 0,6491 0,1570 
Doll & Hill 1952 2714 1350 1357 1289 1357 10,17 4,66 22,23 0,99742 0,0361090641 0,8493 0,1371 0,4724 
Lombard et. al 1965 2080 1026 1040 928 1040 8,84 5,04 15,53 0,99327 0,1884615385 0,6642 0,1975 0,4394 
Wynder et. al 1979 10231 659 684 5156 9547 22,45 15,03 33,54 0,99756 0,9137426901 0,3391 0,2135 -0,3648 
Benhamou et al. 1985 3132 1184 1217 1392 1915 13,48 9,40 19,33 0,98946 0,8948233361 0,3442 0,3138 0,2110 
Harris et. al 1993 5530 2829 2916 1997 2614 10,05 7,97 12,67 0,98427 2,5956790123 0,1072 0,3089 0,4000 
Pershagen et. al 1994 3983 1100 1136 2607 2847 2,81 1,97 4,02 0,99096 1,1408450704 0,2855 0,0935 0,2159 
Sobue et. al 1994 2197 1022 1056 1013 1141 3,80 2,58 5,60 0,98452 1,0946969697 0,2954 0,1529 0,4069 
Jöckel et. al 1998 2008 949 1004 768 1004 5,30 3,89 7,22 0,97261 3,0129482072 0,0826 0,2561 0,3551 
Kreuzer et. al 1998 3470 1687 1709 1358 1761 22,76 14,73 35,16 0,99366 0,2832065535 0,5946 0,3294 0,3700 
Boffetta et al. 1999 12876 5504 5621 5505 7255 14,95 12,36 18,10 0,99091 2,4353317915 0,1186 0,3104 0,2916 
 Total  48393 17393 17826 22043 30567    0,9911 12,70    
          Alpha = 0,05    
        Degrees of freedom = 11    
        X² CRITICAL (SINE) = 19,68    
        X² Calculated (SINE) = 12,70    
        p value (SINE) = 0,31    
 
Table 2: Smoking6, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 is the cause of lung cancer. 
Study ID Year N Case_P Case_T Con_P Con_T X2 
(Sine) 
k k 
lower  
k upper  p value (k) 
Müller 1939 172 83 86 30 86 0,10 0,65 0,48 0,82 0,0000000000 
Doll & Hill 1952 2714 1350 1357 1289 1357 0,04 0,14 0,09 0,18 0,0000000000 
Lombard et. al 1965 2080 1026 1040 928 1040 0,19 0,20 0,15 0,25 0,0000000000 
Wynder et. al 1979 10231 659 684 5156 9547 0,91 0,21 0,19 0,24 0,0000000000 
Benhamou et al. 1985 3132 1184 1217 1392 1915 0,89 0,31 0,27 0,35 0,0000000000 
Harris et. al 1993 5530 2829 2916 1997 2614 2,60 0,31 0,28 0,34 0,0000000000 
Pershagen et. al 1994 3983 1100 1136 2607 2847 1,14 0,09 0,06 0,13 0,0000000001 
Sobue et. al 1994 2197 1022 1056 1013 1141 1,09 0,15 0,11 0,20 0,0000000000 
Jöckel et. al 1998 2008 949 1004 768 1004 3,01 0,26 0,21 0,31 0,0000000000 
Kreuzer et. al 1998 3470 1687 1709 1358 1761 0,28 0,33 0,29 0,37 0,0000000000 
Boffetta et al. 1999 12876 5504 5621 5505 7255 2,44 0,31 0,29 0,33 0,0000000000 
 Total  48393 17393 17826 22043 30567 12,70 0,32 0,31 0,32635 0,0000000000 
            
       Alpha = 0,05    
     Degrees of freedom = 11    
     X² CRITICAL (k) = 19,68    
     X² Calculated (k) = 4837,90    
     p value (SINE) = 0,00    
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Statistical Analysis    
All the statistics analyses were conducted by Microsoft ® 
Excel ® for Mac ® version  16.2 (181208) software (© 
2018, Microsoft GmbH, Munich, Germany). A p <  0.05 was 
considered significant on statistical analyses. 
Definitions 
Definition. The 2x2 Table 
Consider the case of Bernoulli trials (period of time) with 
probability p(at) for success. Let at = 1 if the t-th outcome is a 
success and 0 if it is a failure. Then a = (a1 + a2 + ... + an) is the 
number of successes in n trials (period of time) t. It is p(at)= 
p(At  Bt) the joint probability of At and Bt and  
 
                  
   
   
 (1) 
Let bt = 1 if the t-th outcome is a success and 0 if it is a failure. 
Then b = (b1 + b2 + ... + bn) is the number of successes in n 
Bernoulli trials (period of time) t. It is p(bt)= p(At  Bt) the 
joint probability of (At and Bt) and 
 
                  
   
   
 (2) 
Let ct = 1 if the t-th outcome is a success and 0 if it is a failure. 
Then c = (c1 + c2 + ... + cn) is the number of successes in n 
Bernoulli trials (period of time) t. It is p(ct)= p(At  Bt) the 
joint probability of (At and Bt) and 
 
                  
   
   
 (3) 
Let dt = 1 if the t-th outcome is a success and 0 if it is a failure. 
Then d = (d1 + d2 + ... + dn) is the number of successes in n 
Bernoulli trials (period of time) t. It is p(dt)= p(At  Bt) the 
joint probability of (At and Bt) and 
 
                  
   
   
 (4) 
Let A denote another binomial random variable with the 
probability p(At). It is At = (at + bt) at the same Bernoulli trial 
(period of time) t and 
 
                                 
   
   
 (5) 
Let A denote the complementary random variable of the 
binomial random variable A with the probability p(At). It is At 
= (ct + dt) at the same Bernoulli trial (period of time) t and 
 
                                 
   
   
 (6) 
Let B denote another binomial random variable with the 
probability p(Bt). It is Bt = (at + ct) at the same Bernoulli trial 
(period of time) t and 
 
                                 
   
   
 (7) 
Let B denote the complementary random variable of the 
binomial random variable B with the probability p(Bt). It is Bt 
= (ct + dt) at the same Bernoulli trial (period of time) t and 
 
                                 
   
   
 (8) 
At each Bernoulli trial it is 
                              (9) 
and the sample size n itself equal to 
 
                
 
   
       
 
   
       
 
   
 (10) 
The meaning of the abbreviations a, b, c, d, n et cetera are 
explained by following 2 by 2-table (Table 3). 
Table 3. The sample space of a contingency table 
  
Conditioned B 
(Outcome) 
 
  Yes = +1 No = +0 Total 
Condition A 
(risk factor) 
Yes =+1 a  b A 
No = +0 c d A 
 Total B B n 
 
In this context, it is p(At) = p(at)+p(bt) or p(At) = p(At Bt)+ 
p(bt) or p(At) = p(At Bt)+p(At Bt) while p(At) is not 
identical with p(at). Thus far, it is p(Bt) = p(at)+p(ct) or p(Bt) 
= p(At Bt) +p(ct) and equally p(Bt) = 1- p(Bt) or p(Bt) = 
p(bt)+p(dt). Since the joint probability of At and Bt is denoted 
in general by p(At Bt), it is p(At Bt) = p(At) - p(bt) or  
p(AtBt)=p(Bt) - p(ct) or in other words p(Bt) + p(bt) - p(ct) = 
p(At). In general, it is p(at)+p(ct)+p(bt)+p(dt). The following 
table may show the relationship in more details. 
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Table 4. The probabitlities of a contingency table 
  
Conditioned 
B 
 
  Yes = +1 No = +0 Total 
Condition A 
Yes =+1 p(at)  p(bt) p(At) 
No = +0 p(ct) p(dt) p(At) 
 Total p(Bt) p(Bt) 1 
Definition. Index of unfairness 
The index of unfairness (IOU) is defined as 
 
      
   
 
     (11) 
Definition. Independence 
Let At denote random variable at a Bernoulli trial (period of 
time) t. Let Bt denote another random variable at the same 
Bernoulli trial (period of time) t. Let p(At) denote the 
probability of At. Let p(Bt) denote the probability of Bt. Let 
p(At  Bt) denote the joint probability of At and Bt. In the case 
of independence21, 22 of At and Bt it is generally valid that 
                      (12) 
Definition. Sufficient Condition (Conditio per Quam) 
The mathematical formula of the sufficient condition 
relationship 23, 24, 25, 26, 27, 28, 29, 30, 31  (conditio per quam) of a 
population is defined as
 
 
         
              
  
  
                  
            
            
    
 (13) 
 
and is used to prove the hypothesis: if At then Bt or is taken to 
express that the occurrence of an event At is a sufficient 
condition32,33 for existence or occurrence of an event Bt. The 
occurrence of an event At is a sufficient condition for 
occurrence of the event Bt or Bt is a necessary condition for 
At. In other words, sufficient and necessary conditions are 
converse relations. 
Definition. The X² Test of Goodness of Fit of a Sufficient 
Condition 
A random sample of observations can come from a particular 
distribution (sufficient condition distribution) but must not. 
The X² test of goodness-of-fit is an appropriate method for 
testing the null hypothesis that a random sample of 
observations comes from a specific distribution (i.e. the 
distribution of a sufficient condition) against the alternative 
hypothesis that the data have some other distribution. The 
additive property of X² distribution may sometimes be used 
as an additional test of significance. In this case, the 
continuity correction should be omitted from each X² value. 
Under conditions where the chi-square goodness of fit test 
cannot be used it is possible to use an approximate and 
conservative (one sided) confidence interval known as the 
rule of three. The X² distribution is a particular type of a 
gamma distribution and widely applied in the field of 
mathematical statistics. The applicability of using the 
Pearson chi-squared statistic in cases where the cell 
frequencies of a 2× 2 contingency table are not greater than 
five is widely discussed34 in literature and the use of Yate’s35 
continuity correction is proposed. However, studies provided 
evidence that incorporating Yate’s continuity correction36 is 
not essential37. Still, using the continuity correction, the 
chi-square value of a conditio per quam relationship is 
derived 23, 24, 25, 26, 27, 28, 29, 30, 31 as
 
            
           
 
 
     () 
Barukčić et al                                      Journal of Drug Delivery & Therapeutics. 2019; 9(1-s):148-160 
ISSN: 2250-1177                               [153]                              CODEN (USA): JDDTAO 
or alternatively as 
 
            
           
 
 
     (14) 
Definition. Necessary Condition (Conditio Sine Qua Non) 
Among the many generally valid natural laws and principles 
under which nature or matter itself assures its own 
self-organization, a relationship between events denoted as a 
necessary 23, 24, 25, 26, 27, 28, 29, 30, 31 condition (a conditio sine qua 
non) is one among the most important. A necessary (or an 
essential) event or condition At for some event Bt is a 
condition that must be satisfied in order to obtain Bt. In this 
respect, to say that an event At with its own probability p(At) 
is at the same (period of) time t a necessary condition for 
another event Bt with its own probability p(Bt) is equivalent 
to say that it is impossible to have Bt without At. In other 
words, without At no Bt or the absence of At guarantees the 
absence of Bt. The mathematical formula of the necessary 
condition relationship (conditio sine qua non) of a population 
is defined as
 
 
         
              
  
  
                  
            
                            
    
 (15) 
 
Definition. The X² Test of Goodness of Fit of a Necessary 
Condition 
Under conditions where the chi-square goodness of fit test 
cannot be used it is possible to use an approximate and 
conservative (one sided) confidence interval known as the 
rule of three. Using the continuity correction, the chi-square 
value of a conditio sine qua non distribution 23, 24, 25, 26, 27, 28, 29, 
30, 31 before changes to
 
 
            
           
 
 
     (16) 
Depending upon the study design, another method to 
calculate the chi-square value of a conditio sine qua non 
distribution (while using the continuity correction) is defined 
as
 
 
            
           
 
 
     (17) 
Definition. Exclusion (At Excludes Bt and Vice Versa Relationship) 
The mathematical formula of the exclusion relationship (At excludes Bt and vice versa) of a population was defined 23, 24, 25, 26, 27, 28, 
29, 30, 31 as 
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 (18) 
and used to prove the hypothesis: At excludes Bt and vice 
versa. Why should At exclude Bt and vice versa? Under which 
conditions can such a relationship be given? 
Definition. The X² Test of Goodness of Fit of the Exclusion 
Relationship 
The chi square value with degree of freedom 2-1=1of the 
exclusion relationship 23, 24, 25, 26, 27, 28, 29, 30, 31 with a continuity 
correction can be calculated as
 
            
           
 
 
     (19) 
Depending upon the study design, another method to calculate the chi-square value of a conditio sine qua non distribution is 
defined as 
 
            
           
 
 
     (20) 
The chi square Goodness of Fit Test of the exclusion 
relationship examines how well observed data compare with 
the expected theoretical distribution of an exclusion 
relationship. 
Definition. The Mathematical Formula of the Causal 
Relationship k 
The mathematical formula of the causal relationship k 23, 24, 25, 
26, 27, 28, 29, 30, 31 is defined at every single event, at every single 
Bernoulli trial t, as
 
         
                     
                                
 
 (21) 
where At denotes the cause and Bt denotes the effect. Under 
some certain circumstances, the chi-square distribution can 
be applied to determine the significance of causal 
relationship k. Pearson’s concept of correlation is not 
identical with causation. Causation as such is not identical 
with correlation. This has been proved many times and is 
widely discussed in many publications.  
Definition. The 95% Confidence Interval of the Causal 
Relationship k 
A confidence interval (CI) of the causal relationship k 
calculated from the statistics of the observed data can help to 
estimate the true value of an unknown population parameter 
with a certain probability. Under some conditions, the 95% 
interval for the causal relationship k is derived as
 
 
           
 
 
 
           
 
 
 
  (22) 
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Definition. The rule of three   
Under some specified conditions (i. e. the dataset analyzed is 
large enough or n, the sample size, is n ~ 30 and more), a 
Chi-square38 goodness of fit test is able to provide evidence 
whether a sample distribution observed is identical with a 
theoretical distribution expected. Formally, the Chi-square 
goodness of fit test is defined as X2 = ((sample distribution) - 
(theoretical distribution))2/(theoretical distribution) or 
something like X2=((observed)-(expected))2/(expected). An 
approximate and conservative (one sided) confidence 
interval as discussed39,40,41,42 by and known as the rule of 
three can be of practical value if the Chi-square goodness of 
fit test cannot be applied. Under some circumstances, the rule 
of three derived as 
 
             
 
 
  (23) 
while n is the sample size is one way to calculate the 
probability of events which occur with a probability near 1. 
Another and a very simple path to calculate the probability of 
an event can be performed by the following method. 
Definition. The unknown population proportion upper  
Tests of hypotheses concerning the sampling distribution of 
the sample proportion p (i. e. conditio sine qua non p(SINE), 
conditio per quam p(IMP) et cetera) can be performed using 
the normal approximation. The calculation of the rejection 
region based on the sample proportion to construct a 
confidence interval for an unknown population proportion 
upper can be performed under conditions of sampling without 
replacement (Sachs, 1992) by the formula
 
                   
 
   
       
       
 
   
   
   
 
 
  (24) 
while the term ((N-n)/(N-1)) denotes the finite43 population 
correction. 
Definition. Odds Ratio  
The odds44,45,46,47 ratio, abbreviated as OR(A,B), is a very 
commonly used measure of association for 2× 2 contingency 
tables and given by
 
 
         
   
   
 
   
   
 (25) 
Although severely and justifiably criticized especially by Karl 
Pearson (1857–1925), the long-time and rarely challenged 
leader of statistical science and Heron48, Odds ratio is still 
regularly referred to. The standard error and 95% confidence 
interval of the Odds ratio (OR) can be calculated according to 
Altman49. Given the severely limited character of odds ratio, 
the standard error of the log Odds ratio is calculated as
 
 
                  
 
 
   
 
 
   
 
 
   
 
 
 
 
 (26) 
where ln denotes the logarithmus naturalis. The 95% confidence interval of the odds ratio is given by 
 
                                              
  
                                       
 (27) 
Definition. The Chi-square goodness-of fit test  
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A Chi-Square goodness-of fit test is one of commonly used 
methods of statistical inference an originally proposed by 
Karl Pearson. Given some conditions (simple random 
sampling, categorical random variable, expected value of the 
number of sample observations is at least 5 et cetera), the 
chi-square goodness of fit test can be applied to determine 
whether (sample distribution) data observed are consistent 
with (theoretical distribution) hypothesized data. The degrees 
of freedom (d.f.) of a chi-square goodness of fit test is equal to 
the number of levels (k) of the categorical variable minus 1. 
In general, the chi-square goodness of fit test is given by
 
     
                
 
         
 
   
 (28) 
Example. 
Suppose, a coin is tossed 100 times with the results given in Table 3. 
Table 5. A fair coin. 
Event Observed (xt) Expected (np(xt)) ((xt)- (np(xt))) (((xt)- (np(xt)))2)/ (np(xt)) 
Heads 40 50 -10 (-10)2/50 = 2 
Tails 60 50 +10 (+10)2/50 = 2 
n 100 100  X2 = 4 
 
In this context, the chi-square goodness of fit test50 requires 
to state a null hypothesis (H0) and an alternative hypothesis 
(HA). In point of fact, it is p=p(Heads) and q=p(Tails) and (p 
+q) = 1 or (p(Heads) + p(Tails)) = 1 or p(Tails) = 1 – 
p(Heads). In our present case ( = 0.05), for a chi-square 
goodness of fit test of this example, the hypotheses take the 
following form. 
Null hypothesis: The data are consistent with a specified 
distribution or p(Heads) =0.5 
The null hypothesis claims equally that    
p(Heads) = 1 –p(Tails) = 0.5 
Alternative hypothesis:  The data are not consistent with a 
specified distribution. The Null hypothesis is not true. 
 The value of the test statistics as calculated before is
 
     
                
 
         
 
   
 
        
  
 
        
  
  
   
  
 
   
  
       (29) 
with d. f. = k-1=2-1 = 1. Unfortunately, the p-value of X2=4 is 
less than the significance level (0.05). We accept the 
alternative hypothesis and reject the null-hypothesis. The 
sample data do not provide support for the hypothesis that 
the coin tossed is fair. In general, it is not necessary that p = q, 
to be able use the chi square goodness-of fit test which is the 
mathematical the foundation of the chi square goodness of fit 
test of the necessary condition, of a sufficient condition et 
cetera with d. f. = k-1=2-1 = 1. 
Definition. The Chi Square Distribution 
The following critical values of the chi square distribution as 
visualized by Table 4 are used in this publication.
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Table 6. The critical values of the chi square distribution (degrees of freedom: 1) 
  p-Value One sided X² Two sided X² 
The chi square 
distribution 
 
0.1000000000 
0.0500000000 
0.0400000000 
0.0300000000 
0.0200000000 
0.0100000000 
0.0010000000 
0.0001000000 
0.0000100000 
0.0000010000 
0.0000001000 
0.0000000100 
0.0000000010 
0.0000000001 
1.642374415 
2.705543454 
3.06490172 
3.537384596 
4.217884588 
5.411894431 
9.549535706 
13.83108362 
18.18929348 
22.59504266 
27.03311129 
31.49455797 
35.97368894 
40.46665791 
2.705543454 
3.841458821 
4.217884588 
4.709292247 
5.411894431 
6.634896601 
10.82756617 
15.13670523 
19.51142096 
23.92812698 
28.37398736 
32.84125335 
37.32489311 
41.82145620 
 
RESULTS 
Theorem. Without smoking no lung cancer 
Claims. 
Null hypothesis: 
Smoking is a necessary condition (a conditio sine qua non) of 
lung cancer. In other words, the sample distribution of the 
study analyzed agrees with the hypothetical (theoretical) 
distribution of a necessary condition. 
Alternative Hypothesis: 
Smoking is not a necessary condition (a conditio sine qua 
non) of lung cancer. In other words, the sample distribution 
of the study analyzed does not agree with the hypothetical 
(theoretical) distribution of a necessary condition. 
The significance level (Alpha) below which the null 
hypothesis will be rejected is alpha= 0.05. 
Proof.         
The results of the data reviewed and re-analyzed by this 
article which investigated the relationship between smoking 
and lung cancer are viewed by the table (Table 1). 
Altogether, 11 studies with a sample size of n = 48393 were 
meta-analyzed while the level of significance was alpha = 
0.05. In toto, all studies re-analyzed provide significant 
evidence of a conditio sine qua non relationship (X² 
Calculated (SINE) = 12.70 and is less than X² Critical (SINE) = 
19.68) between a smoking and lung cancer. All studies 
analyzed were able to provide evidence of a significant, 
positive cause effect relationship. In other words, the 
null-hypothesis cannot be rejected, the data analyzed support 
the null-hypothesis: without smoking no lung cancer. 
Quod erat demonstrandum. 
Theorem. Smoking is the cause of lung cancer 
Claims.         
Null Hypothesis:         
Smoking is not the cause of lung cancer. In other words. k = 0. 
Alternative Hypothesis:         
Smoking is the cause of lung cancer. In other words. k  0. 
The significance level (Alpha) below which the null 
hypothesis will be rejected is alpha=0.05. 
Proof.         
The results of the re-analyses of the data reviewed by this 
article (Table 2) which investigated the causal relationship 
between smoking and lung cancer are viewed by the table 
(Table 2). Altogether, 11 studies were meta-analyzed while 
the level of significance was alpha = 0.05. In toto, 11 from 11 
studies provided significant evidence of a causal relationship 
between a smoking and human lung cancer. In the same 
respect, smoking is a necessary (Table 1) condition of lung 
cancer. In other words, without smoking no lung cancer. Thus 
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far, the conclusion is inescapable: smoking of tobacco is the 
cause of human lung cancer (k ~ 0.32, X² Calculated (k) = 
4837.90 and is greater than X² Critical (k) =19.68). 
Quod erat demonstrandum. 
DISCUSSION 
Based on the results of this study, smoking is a necessary 
condition (a conditio sine qua non) of lung cancer. In other 
words, without smoking of tobacco no lung cancer (Table 1). 
In the same respect the cause-effect relationship k (Table 2) 
is highly significant. Firstly, without smoking of tobacco no 
lung cancer will not develop. Secondly. There is a highly 
significant cause effect relationship between smoking and 
lung cancer. Thus far, we are authorized to deduce that 
smoking of tobacco is not only one cause of lung cancer but 
smoking of tobacco is the cause of human lung cancer. Still, 
the lung cancer risk as associated with secondhand smoking 
has not been addressed by this review in an appropriate way. 
The association between passive smoking and lung cancer 
has been investigated by several other studies. With regard 
to this problem, the results of several other studies clearly 
indicate that non-smokers exposed to Environmental 
Tobacco Smoke (ETS) are at increased risk51, 52, 53 of lung 
cancer. In particular, about 433 from 48393 patients (Table 
7) have been treated as never smoker while in reality it 
cannot be excluded that these patients were exposed to 
passive smoking.
 
   
Table 7.     Statistical analysis. Index of unfairness = 0,183 
The studies re-analysed causal relationship k = 0,316181947.    95 % CI (k): (0,30- 0,326)  
  Lung cancer p-value ( k | HGD) = 0 X2 (k) = 4838 
  YES NO  Odds ratio (OR) = 15,53;  95 % Cl(OR) 14,07 17,14 
Smoking YES 17393 22043 39436 p ( SINE ) = 0,991052425 X2 (SINE) = 12,7 
 NO 433 8524 8957     
  17826 30567 48393     
 
The suspicion appears to be justified that through the years 
of smoking an active or passive smoker transfers his own 
lungs into a kind of a “hazardous waste landfill” for a wide 
variety of cancerogenic toxins with all the consequences 
which might follow by time. In order to further clarify the 
association between smoking and lung cancer any exposure 
to environmental tobacco smoke (ETS) should be considered 
by the studies performed. 
CONCLUSION 
The list of studies which provided striking evidence on the 
relationship between smoking and lung cancer is long 
enough and justifies taking a short way around. A total ban 
on smoking is necessary. In any case, smoking is the cause of 
lung cancer. 
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